the anticancer poperties of diosgenin on colorectal cancer cells induced by wnt/β catenin signaling pathway

Background: colorectal cancer (cc) is one of the most prevalent cancers globally. due to the severe side effects and the development of drug resistance in cc treatments, current therapeutic strategies often prove ineffective. as a result, there is a growing interest in exploring traditional medicinal plants as alternative treatment options for various human diseases. diosgenin, a bioactive compound derived from plants, has shown potential in inhibiting the growth of human cc cells. the wnt/β-catenin signaling pathway plays a critical role in colorectal tumorigenesis. objectives: this study investigates the effects of diosgenin on the wnt/β-catenin pathway in cc cells. methods: colorectal cancer cells were treated with diosgenin, and cell viability and plasma membrane integrity were assessed using the mtt assay and lactate dehydrogenase (ldh) activity assay, respectively. apoptosis was evaluated through annexin v/pi staining. the expression of wnt/β-catenin-related genes was analyzed by quantitative pcr (qpcr). results: diosgenin significantly inhibited cc cell viability in a time- and concentration-dependent manner after 24, 48, 72, and 96 hours of exposure (p < 0.05). the ic50 values were determined to be 203.55, 122.95, 70.11, and 7.34 µm at 24, 48, 72, and 96 hours, respectively. diosgenin at its ic50 concentration induced a significant increase in cell apoptosis after 24 hours of treatment (p < 0.05). additionally, it caused a significant reduction in the expression of β-catenin, cyclin d1, and pin1 (βcp). conclusions: diosgenin exhibits anti-cc effects by inhibiting the expression of βcp genes involved in the wnt/β-catenin pathway, suggesting its potential as a therapeutic agent for cc.